sales@fnfresearch.comTel: +91 96043 17127 | USA: 1 (347) 690-0211

Search Market Research Report

Home / Category / Pharmaceuticals / Drug Delivery in Cancer

Drug Delivery in Cancer Market By Product (Liposomes, PEGylated Proteins & Polypeptides, Polymer Nanoparticle, Protein–drug Conjugates, and Others), by Application (Hospitals & Clinic, Cancer Treatment Centers, and Others) and Regions: Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026

  • Publish On: Jun-2020
  • Total Pages: 189
  • Report Code: FAF-1157
  • Base Year: 2019
  • Format:

Industry Insights

This specialized and expertise oriented industry research report scrutinizes the technical and commercial business outlook of the drug delivery in cancer industry. The report analyzes and declares the historical and current trends analysis of the drug delivery in cancer industry and subsequently recommends the projected trends anticipated to be observed in the drug delivery in cancer market during the upcoming years.

The drug delivery in cancer market report analyzes and notifies the industry statistics at the global as well as regional and country levels in order to acquire a thorough perspective of the entire drug delivery in cancer market. The historical and past insights are provided for FY 2016 to FY 2019 whereas projected trends are delivered for FY 2020 to FY 2026. The quantitative and numerical data is represented in terms of both volume (Units) and value (USD Million) from FY 2016 – 2026.

The quantitative data is further underlined and reinforced by comprehensive qualitative data which comprises various across-the-board market dynamics. The rationales which directly or indirectly impact the drug delivery in cancer industry are exemplified through parameters such as growth drivers, restraints, challenges, and opportunities among other impacting factors.

Throughout our research report, we have encompassed all the proven models and tools of industry analysis and extensively illustrated all the key business strategies and business models adopted in the drug delivery in cancer industry. The report provides an all-inclusive and detailed competitive landscape prevalent in the drug delivery in cancer market.

The report utilizes established industry analysis tools and models such as Porter’s Five Forces framework to analyze and recognize critical business strategies adopted by various stakeholders the drug delivery in cancer involved in the entire value chain of the drug delivery in cancer industry. The market report additionally employs SWOT analysis and PESTLE analysis models for further in-depth analysis.

The report study further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market position in the drug delivery in cancer sector. Key strategic developments in the drug delivery in cancer market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the drug delivery in cancer market are appropriately highlighted in the report.

The drug delivery in cancer market research report delivers an acute valuation and taxonomy of the drug delivery in cancer industry by practically splitting the market on the basis of different component, application, end-user, and regions. Through the analysis of the historical and projected trends, all the segments and sub-segments were evaluated through the bottom-up approach, and different market sizes have been projected for FY 2020 to FY 2026. The regional segmentation of the drug delivery in cancer industry includes the complete classification of all the major continents including North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Further, country-wise data for the drug delivery in cancer industry is provided for the leading economies of the world.

Increasing funding around the globe by government for cancer research is a major factor driving target market growth. Additionally, the rising occurrence of chronic diseases, coupled with growth in the aging population are some among the major factors expected to accelerate target demand growth in the near future. Nevertheless, the high cost of associated with the research development is key factor to hinder growth of the global drug delivery in cancer market.

The drug delivery in cancer market is segmented based on type, application, and geography. On the basis of type the target market can be segmented as Liposomes, PEGylated Proteins & Polypeptides, Polymer Nanoparticle, Protein–drug Conjugates, and Others. Based on application segment the global market can be divided into hospitals & clinic, cancer treatment centers, and others. On the basis of application segment the cancer treatment centers are expected to register significant CAGR over the forecast year in the target market.

Some of the essential players operating in the drug delivery in cancer market, but not restricted to include Amgen, Teva, UCB (Union Chimique Belge), Roche, Celgene, Sanofi, Merck, Johnson & Johnson, Takeda, and Gilead Sciences. Major companies in the global drug delivery in cancer market are trying to focus on the inorganic business strategies including launches of innovative products along with strategic partnerships.

The taxonomy of the drug delivery in cancer Market industry by its scope and segmentation is as follows:

Global Drug Delivery in Cancer Market: Type

  • Liposomes
  • PEGylated Proteins & Polypeptides
  • Polymer Nanoparticle
  • Protein–drug Conjugates
  • Others

Global Drug Delivery in Cancer Market: Application

  • Hospitals & Clinic
  • Cancer Treatment Centers
  • Others

Global Drug Delivery in Cancer Market: Regional Segmentation Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • The UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

KEY REPORT POINTERS & HIGHLIGHTS:

  • Statistically Validated Analysis of Historical, Current, and Projected Industry Trends with Authenticated Market Sizes Information and Data in terms of Value and Volume, wherever applicable
  • Direct and Indirect Factors that Impacted the Industry as well Projected Rationales expected to affect the industry going forward
  • Micro, Meso, Macro, and In-Depth Analysis of Technically relevant and Commercially viable Segments and Sub-segments of the Market
  • Historical and Projected Company / Vendor / OEM / Supplier Market Shares, Competitive Landscape, and Player Positioning Data
  • Historical and Current Demand (Consumption) and Supply (Production) Scenarios as well as Projected Supply-Demand Scenario Analysis
  • Detailed List of Key Buyers and End-Users (Consumers) analyzed as per Regions and Applications
  • Value Chain and Supply Chain Analysis along with Horizontal and Vertical Integration Scenarios
  • Manufacturing and Production Cost Structure Analysis including Labor Cost, Raw Material Expenses, and Other Manufacturing Expenses, wherever relevant
  • Overview of Key Marketing Strategies and Key Sales Channels Adopted in the Market
  • Market Attractiveness Analysis and Key Investment Opportunity Analysis in the Market going forward
  • Technological Roadmap, Patents Analysis, Potential Substitutes, and Technical Analysis
  • The professionally substantiated market research report study is calculated, constructed, and assembled by implementing a Robust Research Methodology. The Triangular Process comprises a buoyant mix of Exhaustive Primary Research (focused interviews, questionnaires, and ad-hoc surveys) and Extended Secondary Research (paid external databases, proprietary in-house database, and publically-available validated sources), where it is finally triangulated and validated through in-house industry experts, industry leaders, and independent consultants through a tri-level quality check practice.

Table of Content

  1. CHAPTER 1. Executive Summary
  2. CHAPTER 2. Drug Delivery in Cancer market – Type Analysis
    1. 2.1. Global Drug Delivery in Cancer Market – Type Overview
    2. 2.2. Global Drug Delivery in Cancer Market Share, by Type, 2018 & 2025 (USD Million)
    3. 2.3. Liposomes
      1. 2.3.1. Global Liposomes Drug Delivery in Cancer Market, 2016-2026 (USD Million)
    4. 2.4. PEGylated Proteins & Polypeptides
      1. 2.4.1. Global PEGylated Proteins & Polypeptides Drug Delivery in Cancer Market, 2016-2026 (USD Million)
    5. 2.5. Polymer Nanoparticle
      1. 2.5.1. Global Polymer Nanoparticle Drug Delivery in Cancer Market, 2016-2026 (USD Million)
    6. 2.6. Protein–drug Conjugates
      1. 2.6.1. Global Protein–drug Conjugates Drug Delivery in Cancer Market, 2016-2026 (USD Million)
    7. 2.7. Others
      1. 2.7.1. Global Others Drug Delivery in Cancer Market, 2016-2026 (USD Million)
  3. CHAPTER 3. Drug Delivery in Cancer market – Application Analysis
    1. 3.1. Global Drug Delivery in Cancer Market – Application Overview
    2. 3.2. Global Drug Delivery in Cancer Market Share, by Application, 2018 & 2025 (USD Million)
    3. 3.3. Hospitals & Clinic
      1. 3.3.1. Global Hospitals & Clinic Drug Delivery in Cancer Market, 2016-2026 (USD Million)
    4. 3.4. Cancer Treatment Centers
      1. 3.4.1. Global Cancer Treatment Centers Drug Delivery in Cancer Market, 2016-2026 (USD Million)
    5. 3.5. Others
      1. 3.5.1. Global Others Drug Delivery in Cancer Market, 2016-2026 (USD Million)
  4. CHAPTER 4. Drug Delivery in Cancer market – Regional Analysis
    1. 4.1. Global Drug Delivery in Cancer Market Regional Overview
    2. 4.2. Global Drug Delivery in Cancer Market Share, by Region, 2018 & 2025 (Value)
    3. 4.3. North America
      1. 4.3.1. North America Drug Delivery in Cancer Market size and forecast, 2016-2026
      2. 4.3.2. North America Drug Delivery in Cancer Market, by Country, 2018 & 2025 (USD Million)
      3. 4.3.3. North America Drug Delivery in Cancer Market, by Type, 2016-2026
        1. 4.3.3.1. North America Drug Delivery in Cancer Market, by Type, 2016-2026 (USD Million)
      4. 4.3.4. North America Drug Delivery in Cancer Market, by Application, 2016-2026
        1. 4.3.4.1. North America Drug Delivery in Cancer Market, by Application, 2016-2026 (USD Million)
      5. 4.3.5. U.S.
        1. 4.3.5.1. U.S. Market size and forecast, 2016-2026 (USD Million)
      6. 4.3.6. Canada
        1. 4.3.6.1. Canada Market size and forecast, 2016-2026 (USD Million)
    4. 4.4. Europe
      1. 4.4.1. Europe Drug Delivery in Cancer Market size and forecast, 2016-2026
      2. 4.4.2. Europe Drug Delivery in Cancer Market, by Country, 2018 & 2025 (USD Million)
      3. 4.4.3. Europe Drug Delivery in Cancer Market, by Type, 2016-2026
        1. 4.4.3.1. Europe Drug Delivery in Cancer Market, by Type, 2016-2026 (USD Million)
      4. 4.4.4. Europe Drug Delivery in Cancer Market, by Application, 2016-2026
        1. 4.4.4.1. Europe Drug Delivery in Cancer Market, by Application, 2016-2026 (USD Million)
      5. 4.4.5. Germany
        1. 4.4.5.1. Germany Market size and forecast, 2016-2026 (USD Million)
      6. 4.4.6. France
        1. 4.4.6.1. France Market size and forecast, 2016-2026 (USD Million)
      7. 4.4.7. U.K.
        1. 4.4.7.1. U.K. Market size and forecast, 2016-2026 (USD Million)
      8. 4.4.8. Italy
        1. 4.4.8.1. Italy Market size and forecast, 2016-2026 (USD Million)
      9. 4.4.9. Spain
        1. 4.4.9.1. Spain Market size and forecast, 2016-2026 (USD Million)
      10. 4.4.10. Rest of Europe
        1. 4.4.10.1. Rest of Europe Market size and forecast, 2016-2026 (USD Million)
    5. 4.5. Asia Pacific
      1. 4.5.1. Asia Pacific Drug Delivery in Cancer Market size and forecast, 2016-2026
      2. 4.5.2. Asia Pacific Drug Delivery in Cancer Market, by Country, 2018 & 2025 (USD Million)
      3. 4.5.3. Asia Pacific Drug Delivery in Cancer Market, by Type, 2016-2026
        1. 4.5.3.1. Asia Pacific Drug Delivery in Cancer Market, by Type, 2016-2026 (USD Million)
      4. 4.5.4. Asia Pacific Drug Delivery in Cancer Market, by Application, 2016-2026
        1. 4.5.4.1. Asia Pacific Drug Delivery in Cancer Market, by Application, 2016-2026 (USD Million)
      5. 4.5.5. China
        1. 4.5.5.1. China Market size and forecast, 2016-2026 (USD Million)
      6. 4.5.6. Japan
        1. 4.5.6.1. Japan Market size and forecast, 2016-2026 (USD Million)
      7. 4.5.7. India
        1. 4.5.7.1. India Market size and forecast, 2016-2026 (USD Million)
      8. 4.5.8. South Korea
        1. 4.5.8.1. South Korea Market size and forecast, 2016-2026 (USD Million)
      9. 4.5.9. South-East Asia
        1. 4.5.9.1. South-East Asia Market size and forecast, 2016-2026 (USD Million)
      10. 4.5.10. Rest of Asia Pacific
        1. 4.5.10.1. Rest of Asia Pacific Market size and forecast, 2016-2026 (USD Million)
    6. 4.6. Latin America
      1. 4.6.1. Latin America Drug Delivery in Cancer Market size and forecast, 2016-2026
      2. 4.6.2. Latin America Drug Delivery in Cancer Market, by Country, 2018 & 2025 (USD Million)
      3. 4.6.3. Latin America Drug Delivery in Cancer Market, by Type, 2016-2026
        1. 4.6.3.1. Latin America Drug Delivery in Cancer Market, by Type, 2016-2026 (USD Million)
      4. 4.6.4. Latin America Drug Delivery in Cancer Market, by Application, 2016-2026
        1. 4.6.4.1. Latin America Drug Delivery in Cancer Market, by Application, 2016-2026 (USD Million)
      5. 4.6.5. Brazil
        1. 4.6.5.1. Brazil Market size and forecast, 2016-2026 (USD Million)
      6. 4.6.6. Mexico
        1. 4.6.6.1. Mexico Market size and forecast, 2016-2026 (USD Million)
      7. 4.6.7. Rest of Latin America
        1. 4.6.7.1. Rest of Latin America Market size and forecast, 2016-2026 (USD Million)
    7. 4.7. The Middle-East and Africa
      1. 4.7.1. The Middle-East and Africa Drug Delivery in Cancer Market size and forecast, 2016-2026
      2. 4.7.2. The Middle-East and Africa Drug Delivery in Cancer Market, by Country, 2018 & 2025 (USD Million)
      3. 4.7.3. The Middle-East and Africa Drug Delivery in Cancer Market, by Type, 2016-2026
        1. 4.7.3.1. The Middle-East and Africa Drug Delivery in Cancer Market, by Type, 2016-2026 (USD Million)
      4. 4.7.4. The Middle-East and Africa Drug Delivery in Cancer Market, by Application, 2016-2026
        1. 4.7.4.1. The Middle-East and Africa Drug Delivery in Cancer Market, by Application, 2016-2026 (USD Million)
      5. 4.7.5. GCC Countries
        1. 4.7.5.1. GCC Countries Market size and forecast, 2016-2026 (USD Million)
      6. 4.7.6. South Africa
        1. 4.7.6.1. South Africa Market size and forecast, 2016-2026 (USD Million)
      7. 4.7.7. Rest of Middle-East Africa
        1. 4.7.7.1. Rest of Middle-East Africa Market size and forecast, 2016-2026 (USD Million)
  5. CHAPTER 5. Drug Delivery in Cancer market – Competitive Landscape
    1. 5.1. Competitor Market Share – Revenue
    2. 5.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players
    3. 5.3. Strategic Development
      1. 5.3.1. Acquisitions and Mergers
      2. 5.3.2. New Products
      3. 5.3.3. Research & Development Activities
  6. CHAPTER 6. Company Profiles
    1. 6.1. Amgen
      1. 6.1.1. Company Overview
      2. 6.1.2. Amgen Revenue and Gross Margin
      3. 6.1.3. Product portfolio
      4. 6.1.4. Recent initiatives
    2. 6.2. Teva
      1. 6.2.1. Company Overview
      2. 6.2.2. Teva Revenue and Gross Margin
      3. 6.2.3. Product portfolio
      4. 6.2.4. Recent initiatives
    3. 6.3. UCB (Union Chimique Belge)
      1. 6.3.1. Company Overview
      2. 6.3.2. UCB (Union Chimique Belge) Revenue and Gross Margin
      3. 6.3.3. Product portfolio
      4. 6.3.4. Recent initiatives
    4. 6.4. Roche
      1. 6.4.1. Company Overview
      2. 6.4.2. Roche Revenue and Gross Margin
      3. 6.4.3. Product portfolio
      4. 6.4.4. Recent initiatives
    5. 6.5. Celgene
      1. 6.5.1. Company Overview
      2. 6.5.2. Celgene Revenue and Gross Margin
      3. 6.5.3. Product portfolio
      4. 6.5.4. Recent initiatives
    6. 6.6. Sanofi
      1. 6.6.1. Company Overview
      2. 6.6.2. Sanofi Revenue and Gross Margin
      3. 6.6.3. Product portfolio
      4. 6.6.4. Recent initiatives
    7. 6.7. Merck
      1. 6.7.1. Company Overview
      2. 6.7.2. Merck Revenue and Gross Margin
      3. 6.7.3. Product portfolio
      4. 6.7.4. Recent initiatives
    8. 6.8. Johnson & Johnson
      1. 6.8.1. Company Overview
      2. 6.8.2. Johnson & Johnson Revenue and Gross Margin
      3. 6.8.3. Product portfolio
      4. 6.8.4. Recent initiatives
    9. 6.9. Takeda
      1. 6.9.1. Company Overview
      2. 6.9.2. Takeda Revenue and Gross Margin
      3. 6.9.3. Product portfolio
      4. 6.9.4. Recent initiatives
    10. 6.10. Gilead Sciences
      1. 6.10.1. Company Overview
      2. 6.10.2. Gilead Sciences Revenue and Gross Margin
      3. 6.10.3. Product portfolio
      4. 6.10.4. Recent initiatives
  7. CHAPTER 7. Drug Delivery in Cancer — Industry Analysis
    1. 7.1. Drug Delivery in Cancer Market – Key Trends
      1. 7.1.1. Market Drivers
      2. 7.1.2. Market Restraints
      3. 7.1.3. Market Opportunities
    2. 7.2. Value Chain Analysis
    3. 7.3. Technology Roadmap and Timeline
    4. 7.4. Drug Delivery in Cancer Market – Attractiveness Analysis
      1. 7.4.1. By Type
      2. 7.4.2. By Application
      3. 7.4.3. By Region
  8. CHAPTER 8. Marketing Strategy Analysis, Distributors
    1. 8.1. Marketing Channel
    2. 8.2. Direct Marketing
    3. 8.3. Indirect Marketing
    4. 8.4. Marketing Channel Development Trend
    5. 8.5. Economic/Political Environmental Change
  9. CHAPTER 9. Report Conclusion
  10. CHAPTER 10. Research Approach & Methodology
    1. 10.1. Report Description
    2. 10.2. Research Scope
    3. 10.3. Research Methodology
      1. 10.3.1. Secondary Research
      2. 10.3.2. Primary Research
      3. 10.3.3. Models
        1. 10.3.3.1. Company Share Analysis Model
        2. 10.3.3.2. Revenue Based Modeling
        3. 10.3.3.3. Research Limitations

        List of Figures

        FIG. 1 Global Drug Delivery in Cancer Market, 2016-2026 (USD Million)
        FIG. 2 Global Drug Delivery in Cancer Market Share, by Type, 2018 & 2025 (USD Million)
        FIG. 3 Global Liposomes Drug Delivery in Cancer Market, 2016-2026 (USD Million)
        FIG. 4 Global PEGylated Proteins & Polypeptides Drug Delivery in Cancer Market, 2016-2026 (USD Million)
        FIG. 5 Global Polymer Nanoparticle Drug Delivery in Cancer Market, 2016-2026 (USD Million)
        FIG. 6 Global Protein–drug Conjugates Drug Delivery in Cancer Market, 2016-2026 (USD Million)
        FIG. 7 Global Others  Drug Delivery in Cancer Market, 2016-2026 (USD Million)
        FIG. 8 Global Drug Delivery in Cancer Market Share, by Application, 2018 & 2025 (USD Million)
        FIG. 9 Global Hospitals & Clinic Drug Delivery in Cancer Market, 2016-2026 (USD Million)
        FIG. 10 Global Cancer Treatment Centers Drug Delivery in Cancer Market, 2016-2026 (USD Million)
        FIG. 11 Global Others Drug Delivery in Cancer Market, 2016-2026 (USD Million)
        FIG. 12 Global Drug Delivery in Cancer Market Share, by Region, 2018 & 2025
        FIG. 13 North America Drug Delivery in Cancer Market, 2016-2026
        FIG. 14 U.S. Drug Delivery in Cancer Market, 2016-2026
        FIG. 15 Canada Drug Delivery in Cancer Market, 2016-2026
        FIG. 16 Europe Drug Delivery in Cancer Market, 2016-2026
        FIG. 17 Germany Drug Delivery in Cancer Market, 2016-2026
        FIG. 18 France Drug Delivery in Cancer Market, 2016-2026
        FIG. 19 U.K. Drug Delivery in Cancer Market, 2016-2026
        FIG. 20 Italy Drug Delivery in Cancer Market, 2016-2026
        FIG. 21 Spain Drug Delivery in Cancer Market, 2016-2026
        FIG. 22 Rest of Europe Drug Delivery in Cancer Market, 2016-2026
        FIG. 23 Asia Pacific Drug Delivery in Cancer Market, 2016-2026
        FIG. 24 China Drug Delivery in Cancer Market, 2016-2026
        FIG. 25 Japan Drug Delivery in Cancer Market, 2016-2026
        FIG. 26 India Drug Delivery in Cancer Market, 2016-2026
        FIG. 27 South  Korea Drug Delivery in Cancer Market, 2016-2026
        FIG. 28 South-East Asia Drug Delivery in Cancer Market, 2016-2026
        FIG. 29 Rest of Asia Pacific Drug Delivery in Cancer Market, 2016-2026
        FIG. 30 Latin America Drug Delivery in Cancer Market, 2016-2026
        FIG. 31 Brazil Drug Delivery in Cancer Market, 2016-2026
        FIG. 32 Mexico Drug Delivery in Cancer Market, 2016-2026
        FIG. 33 Rest of Latin America Drug Delivery in Cancer Market, 2016-2026
        FIG. 34 The Middle-East and Africa Drug Delivery in Cancer Market, 2016-2026
        FIG. 35 GCC Countries Drug Delivery in Cancer Market, 2016-2026
        FIG. 36 South Africa Drug Delivery in Cancer Market, 2016-2026
        FIG. 37 Rest of Middle-East Africa Drug Delivery in Cancer Market, 2016-2026
        FIG. 38 Competitor Market Share – Revenue
        FIG. 39 Amgen Revenue and Growth Rate
        FIG. 40 Amgen Market Share
        FIG. 41 Teva Revenue and Growth Rate
        FIG. 42 Teva Market Share
        FIG. 43 UCB (Union Chimique Belge) Revenue and Growth Rate
        FIG. 44 UCB (Union Chimique Belge) Market Share
        FIG. 45 Roche Revenue and Growth Rate
        FIG. 46 Roche Market Share
        FIG. 47 Celgene Revenue and Growth Rate
        FIG. 48 Celgene Market Share
        FIG. 49 Sanofi Revenue and Growth Rate
        FIG. 50 Sanofi Market Share
        FIG. 51 Merck Revenue and Growth Rate
        FIG. 52 Merck Market Share
        FIG. 53 Johnson & Johnson Revenue and Growth Rate
        FIG. 54 Johnson & Johnson Market Share
        FIG. 55 Takeda Revenue and Growth Rate
        FIG. 56 Takeda Market Share
        FIG. 57 Gilead Sciences Revenue and Growth Rate
        FIG. 58 Gilead Sciences Market Share
        FIG. 59 Market Dynamics
        FIG. 60 Global Drug Delivery in Cancer – Value Chain Analysis
        FIG. 61 Technology Roadmap and Timeline
        FIG. 62 Market Attractiveness Analysis – By Type
        FIG. 63 Market Attractiveness Analysis – By Application
        FIG. 64 Market Attractiveness Analysis – By Region
        FIG. 65 Market Channel
        FIG. 66 Marketing Channel Development Trend
        FIG. 67 Growth in World Gross Product, 2008-2018

        List of Tables

        TABLE 1 Global Drug Delivery in Cancer Market, 2018 & 2025 (USD Million)
        TABLE 2 Global Drug Delivery in Cancer market, by Type, 2016-2026 (USD Million)
        TABLE 3 Global Drug Delivery in Cancer market, by Application, 2016-2026 (USD Million)
        TABLE 4 Global Drug Delivery in Cancer market, by Region, 2016-2026 (USD Million)
        TABLE 5 North America Drug Delivery in Cancer Market, by Type, 2016-2026 (USD Million)
        TABLE 6 North America Drug Delivery in Cancer Market, by Application, 2016-2026 (USD Million)
        TABLE 7 Europe Drug Delivery in Cancer Market, by Type, 2016-2026 (USD Million)
        TABLE 8 Europe Drug Delivery in Cancer Market, by Application, 2016-2026 (USD Million)
        TABLE 9 Asia Pacific Drug Delivery in Cancer Market, by Type, 2016-2026 (USD Million)
        TABLE 10 Asia Pacific Drug Delivery in Cancer Market, by Application, 2016-2026 (USD Million)
        TABLE 11 Latin America Drug Delivery in Cancer Market, by Type, 2016-2026 (USD Million)
        TABLE 12 Latin America Drug Delivery in Cancer Market, by Application, 2016-2026 (USD Million)
        TABLE 13 The Middle-East and Africa Drug Delivery in Cancer Market, by Type, 2016-2026 (USD Million)
        TABLE 14 The Middle-East and Africa Drug Delivery in Cancer Market, by Application, 2016-2026 (USD Million)
        TABLE 15 Global Drug Delivery in Cancer Market - Company Revenue Analysis 2016-2019 (USD Million)
        TABLE 16 Global Drug Delivery in Cancer Market - Company Revenue Share Analysis 2016-2019(%)
        TABLE 17 Acquisitions and Mergers
        TABLE 18 New Product/Service Launch
        TABLE 19 Research & Development Activities
        TABLE 20 Market Drivers
        TABLE 21 Market Restraints
        TABLE 22 Market Opportunities

Key Insights from Primary Research

  • As per our primary respondents, the global drug delivery in cancer market is set to grow annually at rate of around 7%
  • It was established through primary research that the global drug delivery in cancer market was valued at around 1400 USD million in 2019
  • The “Cancer Treatment Centers” category, on the basis of application segmentation, is expected register significant CAGR over the forecast period
  • Based on region, the North America is expected to account for the revenue share in 2019 in target market

Key Recommendations from Analysts

  • As per our analysts, global drug delivery in cancer  are growing at high CAGR and various end-use industries are aware of this potential market and applications of drug delivery in cancer
  • Growing at a CAGR around 7.1 %, global drug delivery in cancer market provides numerous opportunities for all of the involved stakeholders across the entire value chain
  • Our analysts have identified flow cytometry segment are expected to register highest CAGR in the global market in terms of product segmentations

Market Share – By Application

Industry Major Market Players

  • Amgen
  • Teva
  • UCB (Union Chimique Belge)
  • Roche
  • Celgene
  • Sanofi
  • Merck
  • Johnson & Johnson
  • Takeda
  • Gilead Sciences

Safe and Secure SSL Encrypted

Choose License Type

Inquiry For Buying

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

have a question

HAVE A QUESTION? Executive will help you find what you are looking for.


REQUEST CUSTOMIZATION

Still haven't found what you're looking for? Speak to our Custom Research Team

Learn More
Facts & Factors provides an array of marketing and business research solutions distinctly designed by our expertise for the clients.
Copyright © 2021 Facts & Factors. All Rights Reserved. Sitemap - Privacy Policy - Terms & Conditions